Latest Breaking News On - China century group - Page 1 : comparemela.com

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesDave chennHui shaoChina century groupMeeting of the companyCompany the boardLakeshore biopharma co ltdChina green energy fundInstitute of technologyCompany the interimCouncil memberUniversity of chicago booth school businessYs biopharma co ltdRsys groupExchange square

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongRobin yangHui shaoAlyssa liDave chennRsys groupLakeshore biopharma co ltdCompany the interimCouncil memberCompany the boardSecurities exchangeUniversity of chicago booth school businessCompany registration statement on formChina green energy fundChina century group

YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer

YS Biopharma To Hold Extraordinary General Meeting On May 21, 2024 And Announces The Appointment Of Interim Chief Executive Officer
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesHui shaoDave chennRobin yangAlyssa liChina green energy fundExchange squareSecurities exchangeCompany the interimPrnewswire ys biopharma co ltdSource ys biopharma co ltdCompany the boardCouncil memberCompany registration statement on formChina century group

China-focused growth equity investor Oceanpine closes DeepTech Fund at $400m

China-focused growth equity investor Oceanpine closes DeepTech Fund at $400m Beijing, China. Source: Li Yang/Unsplash Premium Beijing-based growth equity investor Oceanpine Capital has held the final closing of its second US dollar fund, Oceanpine DeepTech Fund, at $400 million to make new bets on deeptech and innovative growth-stage companies in China’s TMT and biotech sectors. Continue reading this story with a subscription to DealStreetAsia. Contact us for corporate subscriptions at subs@dealstreetasia.com. Sign up for our newsletter - The Daily Brief Opt out of receiving The Daily Brief in your inbox everyday REGISTER stories left placeholder You have one free story left this month.

Ansun biopharmaDave chennEnflame technologyOceanpine deeptech fundChina century groupOceanpine capitalDeeptech fundChina centuryHillhouse capitalHorizon roboticsBlack sesameசீனா சிஇஎன்டியுவ்ஆர்ஒய் குழுசீனா சிஇஎன்டியுவ்ஆர்ஒய்ஹில்ஹவுஸ் மூலதனம்அடிவானம் ரோபாட்டிக்ஸ்கருப்பு எள்